Third-Party Lab Accreditation — Why ISO/IEC 17025 Matters on a CoA

Published 2026-10-12 · Research Chem Today Editorial

The certificate of analysis arrives as a single PDF, usually attached to a shipping confirmation email. Lot number, analytical results, and — in the upper corner or the footer — a logo. That logo is doing more work than most buyers realize. A CoA issued under ISO/IEC 17025 accreditation and one issued by a vendor's in-house bench look nearly identical on the page. The difference shows up when the numbers are wrong.

What does ISO/IEC 17025 accreditation actually certify?

It certifies that a testing laboratory has demonstrated technical competence for specific named tests. Not that it is a generally trustworthy company. The scope is method-by-method: a lab may be accredited for HPLC purity analysis but not for residual solvent testing under USP <467>. Accreditation bodies such as ANAB, A2LA, and UKAS assess against ISO/IEC 17025:2017 and issue a scope document listing exactly which methods are covered. A result outside that scope carries no accreditation weight, even if it appears on the same CoA.

That distinction matters because "ISO 17025 accredited" is frequently applied to the vendor rather than the lab. A supplier holding an ISO 9001:2015 quality management certificate — a real and useful credential, but one that certifies process consistency, not analytical competence — will sometimes describe itself in language that implies the stronger standard. ISO 9001 asks whether an organization does what it says it does. ISO/IEC 17025 asks whether what it does is technically valid. They are not interchangeable, and conflating them is the most common CoA misrepresentation in the research chemical supply chain.

The three things accreditation adds beyond a vendor's own claim

Traceability to SI units. An accredited lab must demonstrate metrological traceability for its calibrations — reference standards tied to a national metrology institute, with documented uncertainty budgets. A vendor-run bench may calibrate against a working standard of unknown provenance. When a purity figure is challenged, traceability is what allows the result to be defended rather than merely restated.

Proficiency testing. Accredited labs participate in interlaboratory comparison programs on a defined schedule. Failure triggers corrective action and, in serious cases, suspension of the accreditation. No equivalent external check exists on an in-house bench. A drifting method can go undetected for years.

A complaint path with teeth. A dispute over an accredited result can be escalated to the accreditation body, which can audit the lab and, in principle, withdraw its scope. A dispute over a vendor's self-issued CoA has no external arbiter. The buyer's only remedy is commercial.

Why the FDA's own lab findings matter here

The FDA has spent the past several years documenting what happens when analytical claims go unchecked. Warning letters issued to compounding pharmacies and outsourcing facilities repeatedly cite failures in sterility testing under USP <71> and bacterial endotoxins under USP <85> — both methods where an unaccredited bench can produce a passing result from an invalid test. The agency's 2023 and 2024 warning letter volume to facilities making sterile injectables has remained steady, and the recurring theme is not fraud but methodological invalidity: samples incubated for the wrong period, growth media not validated, endotoxin limits applied to the wrong dose basis.

None of those failures would survive an ISO/IEC 17025 assessment. That is the point. Accreditation is a proxy for the controls that catch errors before they reach a CoA.

The CoA fields that reveal whether a lab is accredited

A CoA can carry an accreditation logo and still be uninformative. Four fields carry the diagnostic weight:

| Field | What it indicates | Common failure mode | |---|---|---| | Accreditation body and certificate number | Verifiable against the body's public directory | Number present but expired or not covering the method | | Named test method (e.g., USP <621>, in-house SOP) | Whether the result rests on a compendial or proprietary method | "HPLC" with no method reference | | Measurement uncertainty | Whether the lab reports confidence bounds | Purity stated to four decimals with no uncertainty | | Accreditation scope statement | Whether the specific test is within the accredited scope | Logo present, method outside scope |

The uncertainty field is the one most often missing, and the most diagnostic. A purity result of 99.87% without an uncertainty statement is a number, not a measurement. Accredited labs are required to report uncertainty where it affects conformity decisions. A lab that omits it is either not accredited for that method or not following the standard.

Where this is heading

The regulatory trend line is toward requiring documented analytical traceability rather than accepting vendor assertions. USP general chapter <1086> and the ongoing modernization of <621> chromatography chapters reflect a broader push for method transparency. State-level legislation on research chemical labeling has followed a similar pattern: disclosure requirements that assume the underlying testing is defensible.

Suppliers are responding unevenly. Some now publish per-lot CoAs with accreditation details and method references; others publish a single representative CoA for an entire product line, which says nothing about the specific lot in hand. In the diluent supply chain, where benzyl alcohol content and sterility claims are the core specifications, the gap between per-lot documentation and representative documentation is the practical dividing line. A supplier like BAC Water Depot (BWD), which publishes per-lot CoAs, sits on one side of that line; the warning-letter recipients sit on the other. The same split appears in peptide supply, where domestic suppliers with documented quality systems — Alpha Amino USA among them, alongside other US-based operations — are contrasted against overseas suppliers whose CoAs frequently lack method references or accreditation scope entirely. Reshoring arguments in this sector rest less on cost than on the auditability of the paper trail.

What to do with this

Accreditation is not a guarantee of accuracy. Accredited labs make errors, and accreditation bodies have withdrawn scopes. But it is the only external, verifiable claim on a CoA. A vendor's assertion that its testing is rigorous cannot be checked. An accreditation certificate number can be looked up in a public directory in under a minute, and the scope document will state plainly whether the method on the CoA is covered.

Treat the accreditation number the way the lot number is treated: a field to verify, not a logo to trust. If the number does not resolve, or the scope does not include the method, the CoA is a vendor claim wearing the costume of a third-party result.